302 related articles for article (PubMed ID: 23928259)
1. Approved and experimental countermeasures against pestiviral diseases: Bovine viral diarrhea, classical swine fever and border disease.
Newcomer BW; Givens MD
Antiviral Res; 2013 Oct; 100(1):133-50. PubMed ID: 23928259
[TBL] [Abstract][Full Text] [Related]
2. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
Aebischer A; Müller M; Hofmann MA
Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
[TBL] [Abstract][Full Text] [Related]
3. A common neutralizing epitope on envelope glycoprotein E2 of different pestiviruses: implications for improvement of vaccines and diagnostics for classical swine fever (CSF)?
van Rijn PA
Vet Microbiol; 2007 Nov; 125(1-2):150-6. PubMed ID: 17561359
[TBL] [Abstract][Full Text] [Related]
4. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.
Reimann I; Depner K; Trapp S; Beer M
Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124
[TBL] [Abstract][Full Text] [Related]
5. Genetically distinct pestiviruses pave the way to improved classical swine fever marker vaccine candidates based on the chimeric pestivirus concept.
Postel A; Becher P
Emerg Microbes Infect; 2020 Dec; 9(1):2180-2189. PubMed ID: 32962557
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence and risk factors for the presence of ruminant pestiviruses in the Dutch swine population.
Loeffen WL; van Beuningen A; Quak S; Elbers AR
Vet Microbiol; 2009 May; 136(3-4):240-5. PubMed ID: 19128896
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of indirect enzyme-linked immunosorbent assay for a screening test to detect antibodies against classical swine fever virus.
Sakoda Y; Wakamoto H; Tamura T; Nomura T; Naito M; Aoki H; Morita H; Kida H; Fukusho A
Jpn J Vet Res; 2012 Aug; 60(2-3):85-94. PubMed ID: 23094583
[TBL] [Abstract][Full Text] [Related]
8. The challenges of classical swine fever control: modified live and E2 subunit vaccines.
Huang YL; Deng MC; Wang FI; Huang CC; Chang CY
Virus Res; 2014 Jan; 179():1-11. PubMed ID: 24211665
[TBL] [Abstract][Full Text] [Related]
9. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response.
van Gennip HG; van Rijn PA; Widjojoatmodjo MN; de Smit AJ; Moormann RJ
Vaccine; 2000 Oct; 19(4-5):447-59. PubMed ID: 11027808
[TBL] [Abstract][Full Text] [Related]
10. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).
Koenig P; Lange E; Reimann I; Beer M
Vaccine; 2007 Apr; 25(17):3391-9. PubMed ID: 17257713
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
[TBL] [Abstract][Full Text] [Related]
12. The potential of antiviral agents to control classical swine fever: a modelling study.
Backer JA; Vrancken R; Neyts J; Goris N
Antiviral Res; 2013 Sep; 99(3):245-50. PubMed ID: 23827097
[TBL] [Abstract][Full Text] [Related]
13. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission.
Lin GJ; Deng MC; Chen ZW; Liu TY; Wu CW; Cheng CY; Chien MS; Huang C
Vaccine; 2012 Mar; 30(13):2336-41. PubMed ID: 22300723
[TBL] [Abstract][Full Text] [Related]
14. Pestivirus control programs: how far have we come and where are we going?
Moennig V; Becher P
Anim Health Res Rev; 2015 Jun; 16(1):83-7. PubMed ID: 26050577
[TBL] [Abstract][Full Text] [Related]
15. Limited BVDV transmission and full protection against CSFV transmission in pigs experimentally infected with BVDV type 1b.
Wieringa-Jelsma T; Quak S; Loeffen WL
Vet Microbiol; 2006 Nov; 118(1-2):26-36. PubMed ID: 16979307
[TBL] [Abstract][Full Text] [Related]
16. Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines.
Wehrle F; Renzullo S; Faust A; Beer M; Kaden V; Hofmann MA
J Gen Virol; 2007 Aug; 88(Pt 8):2247-2258. PubMed ID: 17622629
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics.
Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA
Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022
[TBL] [Abstract][Full Text] [Related]
18. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
[TBL] [Abstract][Full Text] [Related]
19. Intra-host variation structure of classical swine fever virus NS5B in relation to antiviral therapy.
Haegeman A; Vrancken R; Neyts J; Koenen F
Antiviral Res; 2013 May; 98(2):266-72. PubMed ID: 23511203
[TBL] [Abstract][Full Text] [Related]
20. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
